Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.37 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.37 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.37 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.37 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.35 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ADH1B | P00325 | 1/20 | 0.31 |
| ▸ | ADH1C | P00326 | 1/20 | 0.31 |
| ▸ | ADH1A | P07327 | 1/20 | 0.31 |
| ▸ | ADH7 | P40394 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22374375 | 0.91 | KCNH2 (0.39) | KCNH2S1PR4S1PR1S1PR3S1PR5 | |
| SCHEMBL454473 | 0.88 | — | — | |
| Hydrochloric Acid SCHEMBL15848302 | 0.86 | — | — | |
| SCHEMBL24818693 | 0.85 | KCNH2 (0.39) | KCNH2S1PR4S1PR1S1PR3S1PR5 | |
| SCHEMBL22374323 | 0.85 | KCNH2 (0.39) | KCNH2S1PR4S1PR1S1PR3S1PR5 | |
| SCHEMBL24818687 | 0.85 | KCNH2 (0.39) | KCNH2S1PR4S1PR1S1PR3S1PR5 | |
| SCHEMBL8443522 | 0.85 | KCNH2 (0.39) | KCNH2S1PR4S1PR1S1PR3S1PR5 | |
| SCHEMBL18687348 | 0.85 | KCNH2 (0.39) | KCNH2S1PR4S1PR1S1PR3S1PR5 | |
| SCHEMBL20320827 | 0.84 | KCNH2 (0.38) | KCNH2S1PR4S1PR1S1PR3S1PR5 | |
| SCHEMBL18687350 | 0.84 | KCNH2 (0.38) | KCNH2S1PR4S1PR1S1PR3S1PR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624265-B2 | Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof | ADEKA CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| US-20250163281-A1 | THERMOPLASTIC RESIN COMPOSITION FOR FUSED DEPOSITION MODELING, MODELED BODY, AND METHOD FOR PRODUCING SAME | ADEKA CORPORATION (JP) | 2025-05-22 | — | — | US | disclosed |
| EP-4484465-A1 | THERMOPLASTIC RESIN COMPOSITION FOR FUSED DEPOSITION MODELING, MODELED BODY, AND METHOD FOR PRODUCING SAME | ADEKA CORPORATION (JP) | 2025-01-01 | — | — | EP | disclosed |
| WO-2023163017-A1 | THERMOPLASTIC RESIN COMPOSITION FOR FUSED DEPOSITION MODELING, MODELED BODY, AND METHOD FOR PRODUCING SAME | 株式会社ADEKA | 2023-08-31 | — | — | WO | disclosed |
| WO-2023281602-A1 | THERMOPLASTIC RESIN COMPOSITION, MOLDED ARTICLE AND PRODUCT | 三菱電機株式会社 | 2023-01-12 | — | — | WO | disclosed |
| US-20220177757-A1 | ANTISTATIC AGENT, ANTISTATIC COMPOSITION COMPRISING SAME, ANTISTATIC RESIN COMPOSITION COMPRISING SAME, AND MOLDED ARTICLE THEREOF | ADEKA CORPORATION (JP) | 2022-06-09 | — | — | US | disclosed |
| EP-3945102-A1 | ANTISTATIC AGENT, ANTISTATIC COMPOSITION COMPRISING SAME, ANTISTATIC RESIN COMPOSITION COMPRISING SAME, AND MOLDED ARTICLE THEREOF | ADEKA CORPORATION (JP) | 2022-02-02 | — | — | EP | disclosed |
| CN-113680029-A | Method of manufacturing a golf ball and resulting golf ball | 高仕利公司 | 2021-11-23 | — | — | CN | disclosed |
| US-11117862-B2 | Methods of producing molindone and its salts | SUPERNUS PHARMACEUTICALS, INC. (US) | 2021-09-14 | — | — | US | disclosed |
| EP-3196273-B1 | ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION, ANTISTATIC RESIN COMPOSITION, AND MOLDED ARTICLE | ADEKA CORP (JP) | 2021-06-30 | — | — | EP | disclosed |
| EP-2977424-A1 | ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION, ANTISTATIC RESIN COMPOSITION, AND MOLDED ARTICLE | Adeka Corporation (JP) | 2016-01-27 | — | — | EP | disclosed |
| US-20150353796-A1 | ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION, ANTISTATIC RESIN COMPOSITION, AND MOLDED BODY | ADEKA CORPORATION (JP) | 2015-12-10 | — | — | US | disclosed |
| EP-2949721-A1 | ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION, ANTISTATIC RESIN COMPOSITION, AND MOLDED BODY | Adeka Corporation (JP) | 2015-12-02 | — | — | EP | disclosed |
| US-20150141645-A1 | METHODS OF PRODUCING MOLINDONE AND ITS SALTS | SUPERNUS PHARMACEUTICALS, INC. | 2015-05-21 | — | — | US | disclosed |
| US-8957206-B2 | Methods of producing molindone and its salts | SUPERNUS PHARMACEUTICALS INC. (US) | 2015-02-17 | — | — | US | disclosed |
| US-8957206-B2 | Methods of producing molindone and its salts | SUPERNUS PHARMACEUTICALS INC. (US) | 2015-02-17 | — | — | US | disclosed |
| WO-2014042688-A1 | METHODS OF PRODUCING MOLINDONE AND ITS SALTS | SUPERNUS PHARMACEUTICALS INC. (US) | 2014-03-20 | — | — | WO | disclosed |
| US-20140081020-A1 | METHODS OF PRODUCING MOLINDONE AND ITS SALTS | SUPERNUS PHARMACEUTICALS, INC. | 2014-03-20 | — | — | US | disclosed |
| US-20140081020-A1 | METHODS OF PRODUCING MOLINDONE AND ITS SALTS | SUPERNUS PHARMACEUTICALS, INC. | 2014-03-20 | — | — | US | disclosed |
| US-20030105266-A1 | Curable resin composition | YOKOHAMA RUBBER CO., LTD. (JP) | 2003-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11117862-B2 | Methods of producing molindone and its salts | MPI, GMDS, MEN1 | KCNH2 1521/4885S1PR4 3342/4885S1PR1 3362/4885 |
| US-20140081020-A1 | METHODS OF PRODUCING MOLINDONE AND ITS SALTS | MPI, GMDS, MEN1 | KCNH2 1521/4885S1PR4 3342/4885S1PR1 3362/4885 |
| US-20150141645-A1 | METHODS OF PRODUCING MOLINDONE AND ITS SALTS | MPI, GMDS, MEN1 | KCNH2 1521/4885S1PR4 3342/4885S1PR1 3362/4885 |
| US-12624265-B2 | Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof | SORD, SUCLA2, SUCLG1 | KCNH2 4578/4885S1PR4 2404/4885S1PR1 1925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.